Table 1 Clinicopathological data of the ovarian cancer patients
Variable | Ovarian carcinoma (%) |
|---|---|
Total | 86 (100) |
Median age at diagnosis, years | 58 (26–88) |
Histologic subtype | |
Serous | 51 (59) |
High grade | 45 |
Low grade | 6 |
Mucinous | 11 (13) |
Endometrioid | 15 (17) |
High grade | 13 |
Low grade | 2 |
Clear cell | 5 (6) |
Other | 4 (5) |
Ca12–5 median, kU/l | 363 (5–10,100) |
FIGO Stage | |
I | 12 (13) |
II | 10 (12) |
III | 46 (53) |
IV | 18 (22) |
Histological gradea | |
1 | 9 (12) |
2 | 25 (33) |
3 | 41 (55) |
Ascites | 60 (70) |
No ascites | 16 (19) |
No data on ascites | 10 (11) |
Residual tumor at primary surgery | |
None | 40 (47) |
≤ 1 cm | 8 (9) |
> 1 cm | 38 (44) |
Chemotherapy response | |
Complete response | 57 (66) |
Partial response | 4 (5) |
Stable disease | 2 (2) |
Progressive disease | 5 (6) |
No chemotherapy | 5 (6) |
No data | 13 (15) |
Tumor recurrence | 42 (49) |
No recurrence | 25 (29) |
No data on recurrence | 19 (22) |
Patient status | |
Dead from ovarian cancer | 46 (53) |
Alive | 35 (41) |
Median follow-up, months | 65 (0–198) |